1/12
08:05 am
ttrx
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
1/7
04:05 pm
ttrx
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Low
Report
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
1/6
04:10 pm
ttrx
Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
Low
Report
Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
12/31
06:48 am
ttrx
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
Medium
Report
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
12/31
06:48 am
ttrx
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
Medium
Report
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
12/29
08:00 am
ttrx
Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $8.00 price target on the stock.
High
Report
Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $8.00 price target on the stock.
11/13
08:16 am
ttrx
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]
11/13
08:00 am
ttrx
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Medium
Report
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
11/11
04:32 pm
ttrx
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. [Yahoo! Finance]
High
Report
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. [Yahoo! Finance]
11/11
04:05 pm
ttrx
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
High
Report
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
11/11
09:01 am
ttrx
Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine [Yahoo! Finance]
Medium
Report
Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine [Yahoo! Finance]
11/11
08:00 am
ttrx
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
Medium
Report
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
11/4
05:07 pm
ttrx
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
Low
Report
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
10/30
10:00 am
ttrx
Turn Therapeutics signs license deal with surgical product supplier Medline [Seeking Alpha]
Low
Report
Turn Therapeutics signs license deal with surgical product supplier Medline [Seeking Alpha]
10/30
07:30 am
ttrx
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
Low
Report
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
10/22
08:00 am
ttrx
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
High
Report
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones